Compounds in marijuana including THC and CBD show “promising potential as anticancer agents,” according to a recent review of scientific literature. The review by an international team of researchers found several ways that compounds in cannabis can affect cancer, including limiting the growth and spread of tumors and other benefits.
To complete the review, nine researchers from universities in Pakistan, Portugal, Turkey, Saudi Arabia, Romania and South Korea conducted a comprehensive search of several online databases for scientific literature that investigated the association between cannabis and cancer. The authors’ search “focused on peer-reviewed articles, review articles, and clinical trials discussing the anticancer properties of cannabinoids.” To be included in the review, articles had to be written in English and contain information on “the mechanisms of action and clinical efficacy of cannabinoids in cancer.”
Through their analysis, which was published last month in the peer-reviewed journal Discover Oncology, the researchers determined that cannabinoids including delta-9 THC, cannabidiol (CBD) and cannabigerol (CBG) showed “promising potential as anticancer agents through various mechanisms.”
“Cannabinoids, including Δ9-THC, CBD, and CBG, exhibit significant anticancer activities such as apoptosis induction, autophagy stimulation, cell cycle arrest, anti-proliferation, anti-angiogenesis, and metastasis inhibition,” the researchers wrote, online cannabis news source Marijuana Moment reported on Monday. “Clinical trials have demonstrated cannabinoids’ efficacy in tumor regression and health improvement in palliative care.” [Read More @ Forbes]
Copyright
© Cannabis Business Executive
